Bassett Furniture Industries is a retailer, manufacturer and marketer of branded home furnishings. The company's products are sold primarily through a network of the company-owned and licensee-owned branded stores under the Bassett Home Furnishings (BHF) name. The company's wholesale home furnishings segment is involved principally in the design, manufacture, sourcing, sale and distribution of furniture products to a network of BHF stores and independent furniture retailers. The company's Retail segment includes its store network of the company-owned stores and licensee-owned stores. The company's Logistical Services segment provides network line haul freight (middle mile) and warehousing, distribution and inventory management.

Blucora is a provider of technology-enabled financial solutions. The company has two reportable segments: Wealth Management and Tax Preparation. The Wealth Management business consists of the operations of Avantax Wealth Management, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and their clients and is a tax-focused independent broker-dealer. The Tax Preparation business consists of the operations of TaxAct, Inc., which provides digital do-it-yourself tax preparation solutions for consumers, small business owners and tax personnel through its website www.TaxAct.com.

CECO Environmental is a provider of industrial air quality and fluid handling serving the energy, industrial and other markets through an asset-light business model. The company has three reportable segments: Energy Solutions, which provides offerings that improve air quality with engineered, and customized solutions for the power generation, oil and gas, and petrochemical industries; Industrial Solutions, which provides a set of air pollution control technologies to reduce carbon footprint, and lower energy consumption, among others; and Fluid Handling Solutions, which provides pump and filtration solutions that maintain safe and clean operations in harsh and toxic environments.

First Busey is a financial holding company. Through its subsidiary, Busey Bank, the company conducts a range of financial services. The company has three segments: Banking, which provides banking services to individual and corporate customers through its banking center network in Illinois, St. Louis, MO metropolitan area, southwest Florida and through its banking center in Indianapolis, IN; Remittance Processing, which provides for online bill payments, lockbox and walk-in payments; and Wealth Management, which provides a range of asset management, investment and fiduciary services to individuals, businesses and foundations, tax preparation, philanthropic advisory services and farm and brokerage services.

Franklin Financial Network is a financial holding company. Through its wholly owned bank subsidiary, Franklin Synergy Bank, the company provides a range of banking and related financial services which focus on service to small businesses, corporate entities, local governments and individuals. The company's line of financial products include commercial banking, consumer banking, mortgage loans, deposits, retirement planning, financial planning, investment services, and insurance products through its wealth management department. The company operates through branches in WWilliamson, Davidson, and Rutherford counties within the Nashville metropolitan area.

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

La Jolla Pharmaceutical is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for patients suffering from life-threatening diseases. GIAPREZATM (angiotensin II) is approved by the United States Food and Drug Administration as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. LJPC-0118 is the company's investigational product for the treatment of severe malaria. LJPC-401 (synthetic human hepcidin), a clinical-stage investigational product, is being developed for the treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia and polycythemia vera.

Perspecta is a provider of end-to-end enterprise information technology and operations-related services across the United States federal government as well as to certain state and local government agencies. Using its enterprise offerings and solutions, the company assists government customers implement modern collaborative workplaces, hybrid cloud platforms and integrated digital systems of engagement with their enterprise management systems. The company's offerings include application services, analytics and data services, applied research, cybersecurity, cloud computing and infrastructure services, digital strategy and transformation, digital workplace, integrated solutions, and investigative services.

SEACOR Marine Holdings provides global marine and support transportation services to offshore oil, natural gas exploration and windfarm development and production facilities worldwide. The company's fleet features offshore support and specialty vessels that deliver cargo and personnel to offshore installations; handle anchors and mooring equipment required to tether rigs to the seabed; tow rigs and assist in placing them on location and moving them between regions; provide construction, well workover and decommissioning support; carry and launch equipment used underwater in drilling and well installation, maintenance and repair; and provide windfarm installation, maintenance and repair support.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.

Xerox is a workplace technology company. The company's business areas are: Xerox Services, which offerings in this area are Intelligent Workplace Services and a range of Digital Services that utilize the company's software capabilities in Workflow Automation, Personalization and Communication Software, Content Management Solutions, and Digitization Services; Workplace Solutions, which is made up of two product groups, Entry and Mid-Range, which share common technology, manufacturing and product platforms; and Graphic Communications and Production Solutions, which are designed for customers in the graphic communications, in-plant and production print environments with high-volume printing requirements

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.